MBL2 and atherosclerosis: Although the protective or detrimental role of MBL in CVDs is still controversial, as both low and high levels of MBL indicate the susceptibility to CVDs [19,20], our findings provide solid evidence that MBL can be potentially used for immune-modulatory therapy for atherosclerosis.